Market cap
$18 Mln
Revenue (TTM)
$212 Mln
P/E Ratio
--
P/B Ratio
0.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 31.53 | 129.63 | 558.80 | -- | -- |
| EBIT | -490.45 | -357.36 | -90.67 | -266.02 | -- |
| Net Profit | -485.24 | -361.47 | -93.09 | -297.03 | -- |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-21 | Dec-20 |
| EBIT-Margin
| -5,968.69 | -- | -66.78 | -69.36 | -11,868.03 |
| Net Margin
| -- | -- | -67.44 | -- | -- |
| Return on equity
| 13.93 | -- | -107.91 | -102.50 | 101.99 |
| Return on Capital
| 36.93 | -- | -- | -83.74 | 146.23 |
| Return on Assets
| -94.09 | -- | -54.90 | -38.93 | -89.45 |
| Debt to Equity (x)
| -- | -- | 0.48 | 0.01 | -0.41 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
--
|
-83.74
|
146.23
|
48.28
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-107.91
Lower than Peers by 112.85
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
-107.91
|
-102.50
|
101.99
|
42.29
|
--
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
ROA
-54.90
Lower than Peers by 57.35
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
-54.90
|
-38.93
|
-89.45
|
-153.90
|
--
|
|
Peer Median
|
2.45
|
--
|
--
|
--
|
--
|
EBIT Margin
-66.78
Lower than Peers by 75.26
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
-66.78
|
-69.36
|
-11,868.03
|
--
|
--
|
|
Peer Median
|
8.47
|
--
|
--
|
--
|
--
|
Net Margin
-67.44
Lower than Peers by 72.12
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
-67.44
|
-69.67
|
-16,677.70
|
--
|
--
|
|
Peer Median
|
4.68
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
558.80
Higher than Peers by 550.32
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
558.80
|
344.93
|
--
|
--
|
--
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
EBIT Growth
-90.67
Lower than Peers by 101.31
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
-90.67
|
-102.16
|
-130.37
|
-41.19
|
--
|
|
Peer Median
|
10.65
|
--
|
--
|
--
|
--
|
Net Profit Growth
-93.09
Lower than Peers by 106.64
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
-93.09
|
-44.50
|
-390.79
|
-36.05
|
--
|
|
Peer Median
|
13.55
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.48
Higher than Peers by 0.09
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
0.48
|
0.01
|
-0.41
|
-0.04
|
-0.24
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.04
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
0.04
|
0.01
|
-0.01
|
-0.02
|
-0.21
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.46
Lower than Peers by 1.37
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
1.46
|
4.10
|
7.93
|
3.83
|
0.49
|
|
Peer Median
|
2.83
|
--
|
--
|
--
|
--
|
Quick Ratio
0.79
Lower than Peers by 1.26
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
0.79
|
3.09
|
7.38
|
--
|
--
|
|
Peer Median
|
2.05
|
--
|
--
|
--
|
--
|
Interest Coverage
-60.96
Lower than Peers by 65.92
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
-60.96
|
-21,513.33
|
-602.36
|
-153.98
|
-51.66
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
9.06
Lower than Peers by 7.40
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
9.06
|
38.08
|
176.95
|
--
|
--
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.81
Higher than Peers by 0.31
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
0.81
|
0.56
|
0.01
|
--
|
--
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
--
|
70.47
|
1,540.43
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
--
|
122.68
|
915.48
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
--
|
51.49
|
428.29
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
--
|
141.66
|
2,027.62
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
0.19
Lower than Peers by 3.60
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
0.19
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.79
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.15
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
-0.15
|
1.70
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
18
Lower than Peers by 522
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Lucira Health (LHDX)
|
18
|
--
|
--
|
--
|
--
|
|
Peer Median
|
540
|
--
|
--
|
--
|
--
|